PF-06700841
- Generic Name
- PF-06700841
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21F2N7O
- CAS Number
- 1883299-62-4
- Unique Ingredient Identifier
- 3X8387Q25N
- Background
PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers).
- Associated Conditions
- -
- Associated Therapies
- -
Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Emma Guttman
- Target Recruit Count
- 50
- Registration Number
- NCT05076006
- Locations
- ๐บ๐ธ
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids
- Conditions
- Interventions
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 18
- Registration Number
- NCT04267250
- Locations
- ๐บ๐ธ
Quotient Sciences Screening Office, Coral Gables, Florida, United States
๐บ๐ธQuotient Sciences-Miami, Miami, Florida, United States
Renal Impairment Study of PF-06700841
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT04260464
- Locations
- ๐บ๐ธ
Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, United States
๐บ๐ธInvestigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy, Miami, Florida, United States
๐บ๐ธUniversity of Miami Division of Clinical Pharmacology, Miami, Florida, United States
A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
- Conditions
- Interventions
- First Posted Date
- 2019-09-17
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 194
- Registration Number
- NCT04092452
- Locations
- ๐บ๐ธ
Boston Medical Center, Boston, Massachusetts, United States
๐บ๐ธDermatology Associates of Seattle, Seattle, Washington, United States
๐บ๐ธDawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States
A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2020-01-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT04090047
- Locations
- ๐บ๐ธ
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis
- First Posted Date
- 2019-05-24
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 219
- Registration Number
- NCT03963401
- Locations
- ๐ต๐ฑ
RCMed Oddzial Sochaczew, Sochaczew, Poland
๐ต๐ฑZespol Poradni Specjalistycznych "REUMED" Filia nr 2, Lublin, Poland
๐ฆ๐บEmeritus Research, Melbourne, Victoria, Australia
Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
- First Posted Date
- 2019-04-04
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 292
- Registration Number
- NCT03903822
- Locations
- ๐บ๐ธ
Center for Dermatology and Plastic Surgery, Scottsdale, Arizona, United States
๐บ๐ธFirst OC Dermatology, Fountain Valley, California, United States
๐บ๐ธCalifornia Dermatology & Clinical Research Institute, Encinitas, California, United States
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2022-06-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 344
- Registration Number
- NCT03850483
- Locations
- ๐ฏ๐ต
Tanpopo Skin Clinic, Ota Ku, Tokyo, Japan
๐ฑ๐ปAesthetic dermatology clinic of Prof. J. Kisis, Riga, Latvia
๐ฑ๐ปHealth and Aesthetics Ltd, Riga, Latvia
A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers
- First Posted Date
- 2018-09-04
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 33
- Registration Number
- NCT03656952
- Locations
- ๐ง๐ช
Pfizer Clinical Research Unit, Brussels, Belgium
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease
- Conditions
- Interventions
- First Posted Date
- 2018-01-10
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 244
- Registration Number
- NCT03395184
- Locations
- ๐บ๐ฆ
Regional Municipal Non-profit Enterprise "Chernivtsi Regional Clinical Hospital", Surgery Department, Chernivtsi, Ukraine
๐บ๐ธDothan Surgery Center, Dothan, Alabama, United States
๐บ๐ธGut P.C., dba Digestive Health Specialists of the Southeast, Dothan, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.